Maple Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-670
| Closed | -$229K | – | 105 |
|
|
2021
Q2 | $229K | Buy |
+670
| New | +$229K | 0.03% | 103 |
|
|
2020
Q2 | – | Sell |
-781
| Closed | -$247K | – | 99 |
|
|
2020
Q1 | $247K | Hold |
781
| – | – | 0.06% | 80 |
|
|
2019
Q4 | $232K | Sell |
781
-84
| -10% | -$25K | 0.04% | 112 |
|
|
2019
Q3 | $201K | Hold |
865
| – | – | 0.04% | 116 |
|
|
2019
Q2 | $202K | Hold |
865
| – | – | 0.05% | 119 |
|
|
2019
Q1 | $204K | Hold |
865
| – | – | 0.05% | 118 |
|
|
2018
Q4 | $260K | Hold |
865
| – | – | 0.07% | 102 |
|
|
2018
Q3 | $306K | Sell |
865
-4
| -0.5% | -$1.42K | 0.07% | 104 |
|
|
2018
Q2 | $252K | Sell |
869
-15
| -2% | -$4.35K | 0.06% | 114 |
|
|
2018
Q1 | $242K | Sell |
884
-10
| -1% | -$2.74K | 0.06% | 120 |
|
|
2017
Q4 | $285K | Buy |
894
+25
| +3% | +$7.97K | 0.07% | 115 |
|
|
2017
Q3 | $272K | Hold |
869
| – | – | 0.07% | 117 |
|
|
2017
Q2 | $236K | Hold |
869
| – | – | 0.07% | 123 |
|
|
2017
Q1 | $238K | Sell |
869
-20
| -2% | -$5.48K | 0.07% | 122 |
|
|
2016
Q4 | $252K | Buy |
889
+4
| +0.5% | +$1.13K | 0.08% | 112 |
|
|
2016
Q3 | $277K | Buy |
885
+50
| +6% | +$15.7K | 0.09% | 107 |
|
|
2016
Q2 | $202K | Hold |
835
| – | – | 0.07% | 109 |
|
|
2016
Q1 | $217K | Hold |
835
| – | – | 0.08% | 110 |
|
|
2015
Q4 | $256K | Hold |
835
| – | – | 0.09% | 113 |
|
|
2015
Q3 | $244K | Buy |
835
+20
| +2% | +$5.84K | 0.09% | 112 |
|
|
2015
Q2 | $329K | Sell |
815
-22
| -3% | -$8.88K | 0.11% | 101 |
|
|
2015
Q1 | $353K | Sell |
837
-163
| -16% | -$68.7K | 0.12% | 96 |
|
|
2014
Q4 | $339K | Buy |
+1,000
| New | +$339K | 0.12% | 97 |
|